Page 17 - Serum Institute Of India

Poonawalla group firm makes open offer to buy addl stake in Magma Fincorp

Adar Poonawalla-controlled Rising Sun Holdings Pvt Ltd along with two other individuals have made an open offer to buy an additional 26 per cent stake in non-banking financial company Magma Fincorp

With WHO backing, SII to ship Astra Covid-19 vaccine to 70 countries

After audit of Pune plant, Serum may supply vaccines to UK as well

Haven't asked Serum to take back 1 mn Covishield doses, says South Africa

South Africa plans to share AstraZeneca shots via African Union, says Anban Pillay, deputy director-general at the Department of Health

Poonawalla's buyout to aid Magma Fincorp's expansion plans: Analysts

With Poonawalla taking control and fortunes of Magma Fincorp (MFL) expected to change, investors rushed to buy the latter's shares which were locked in the 10 per cent upper circuit band

Adar Poonawalla to acquire 60% in Magma Fincorp for Rs 3,456-crore

As a part of deal, Magma will get fresh capital of Rs 3,456 crore

A shot at recovery

Vaccine delivery needs to move beyond govt control

Top headlines: Setback for Amazon, India to appeal against Cairn verdict

On Monday, the central bank said it would buy bonds worth Rs 20,000 crore from the secondary markets on Wednesday. Read top news with Business Standard here

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

India Coronavirus Dispatch: Serum sitting on a stockpile of 55 mn shots

The nationwide 'R-value' stays steady, over 5 million people vaccinated, Indians locked out of Saudi, and more-news relevant to India's fight against Covid-19

Serum Institute of India delays vaccines for private sale in Bangladesh

Serum is instead prioritising state immunisation campaigns

Serum Institute, UNICEF enter into long-term supply for Covid-19 vaccines

The UN children's agency said it will have access to up to 1.1 billion doses of vaccines for around 100 countries

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine

Govt places second purchase order with SII for 10 mn doses of Covid vaccine

The Centre on Wednesday placed a second purchase order with the Serum Institute of India for the supply of one crore doses of Oxford-AstraZeneca COVID-19 vaccine Covishield'

WHO-led COVAX vaccine scheme agrees new supply deal with Serum Institute

Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme

SII, Bharat Biotech welcome enhanced focus on health in Budget 2021

Serum Institute of India and Bharat Biotech applauded the government's increased allocation for the healthcare sector and on providing Rs 35,000 crore towards Covid-19 vaccination in 2021-22 fiscal.

Relief for SII as court rejects trademark-violation plea over 'Covishield'

A local court has rejected an application seeking injunction against the use of 'Covishield' as brandname by the vaccine-maker Serum Institute of India

Serum Institute seeks DCGI nod for clinical trials of Covid vaccine Covovax

SII is already manufacturing millions of doses of Covishield vaccine in technical collaboration with Oxford University and AstraZeneca

Covid-19: India dispatches Covishield vaccines to Bahrain, Sri Lanka

India's Ministry of External Affairs had announced vaccine rollout for several countries from January 20

India to send 1 million Covid-19 vaccine doses to South Africa on Feb 1

After the arrival of the vaccine doses via Dubai, these will undergo some processes for 10 to 14 days, after which these will be distributed among provinces, he said during a virtual press conference

Serum Institute looking at bilateral deals to supply Covishield vaccine

To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses